Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
BMRN

BioMarin

$94.44

0.43 (0.46%)

, PRQR

ProQR Therapeutics

$15.46

0.55 (3.69%)

07:30
01/14/19
01/14
07:30
01/14/19
07:30
Recommendations
BioMarin, ProQR Therapeutics analyst commentary at Cantor Fitzgerald »

Cantor highlights…

BMRN

BioMarin

$94.44

0.43 (0.46%)

PRQR

ProQR Therapeutics

$15.46

0.55 (3.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

BMRN

BioMarin

$90.93

-1.33 (-1.44%)

08:52
01/10/19
01/10
08:52
01/10/19
08:52
Recommendations
BioMarin analyst commentary at Jefferies »

BioMarin shares well…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMRN

BioMarin

$92.26

2.03 (2.25%)

16:51
01/08/19
01/08
16:51
01/08/19
16:51
Hot Stocks
BioMarin lowers FY18 Kuvan net product revenue view to $430M-$450M »

Prior guidance for FY18…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMRN

BioMarin

$90.83

3.775 (4.34%)

12:02
01/07/19
01/07
12:02
01/07/19
12:02
Hot Stocks
BioMarin sees 2019 global revenue for Palynziq of $70M-$100M »

BioMarin Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

BMRN

BioMarin

$90.58

3.525 (4.05%)

12:00
01/07/19
01/07
12:00
01/07/19
12:00
Hot Stocks
BioMarin says decision to submit valoctocogene roxaparvovec BLA tracking for 2H »

BioMarin Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

BMRN

BioMarin

$90.58

3.525 (4.05%)

11:57
01/07/19
01/07
11:57
01/07/19
11:57
Earnings
BioMarin backs FY18 revenue view of $1.47B-$1.53B, consensus $1.52B »

In slides for its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

CELG

Celgene

$86.30

1.38 (1.63%)

, NVS

Novartis

$84.60

-1.28 (-1.49%)

10:15
01/07/19
01/07
10:15
01/07/19
10:15
Conference/Events
JPMorgan to hold a conference »

37th Annual Healthcare…

CELG

Celgene

$86.30

1.38 (1.63%)

NVS

Novartis

$84.60

-1.28 (-1.49%)

DXCM

DexCom

$127.22

10.98 (9.45%)

MOH

Molina Healthcare

$107.89

-1.82 (-1.66%)

BMRN

BioMarin

$89.63

2.575 (2.96%)

PFE

Pfizer

$42.99

(0.00%)

CAH

Cardinal Health

$44.93

0.03 (0.07%)

GILD

Gilead

$67.82

-0.45 (-0.66%)

VAR

Varian Medical

$119.16

0.4 (0.34%)

BAX

Baxter

$66.46

-0.01 (-0.02%)

ABC

AmerisourceBergen

$74.22

-0.075 (-0.10%)

EW

Edwards Lifesciences

$148.94

0.25 (0.17%)

ATRX

Atrix Laboratories

$0.00

(0.00%)

INCY

Incyte

$74.29

2.02 (2.80%)

JNJ

Johnson & Johnson

$126.99

-0.81 (-0.63%)

NBIX

Neurocrine

$79.49

4.73 (6.33%)

DVA

DaVita

$53.92

-0.09 (-0.17%)

INOV

Inovalon

$13.69

-0.16 (-1.16%)

SIEGY

Siemens

$0.00

(0.00%)

MRK

Merck

$75.87

-0.39 (-0.51%)

BIIB

Biogen

$320.36

2.17 (0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 07

    Jan

  • 07

    Jan

  • 07

    Jan

  • 07

    Jan

  • 11

    Jan

  • 14

    Jan

  • 22

    Jan

  • 23

    Jan

  • 27

    Jan

  • 28

    Jan

  • 28

    Jan

  • 29

    Jan

  • 29

    Jan

  • 29

    Jan

  • 30

    Jan

  • 31

    Jan

  • 31

    Jan

  • 14

    Feb

  • 16

    Feb

  • 18

    Feb

  • 21

    Feb

  • 24

    Feb

  • 11

    Apr

  • 18

    May

  • 28

    May

CELG

Celgene

$84.92

4.4 (5.46%)

, NVS

Novartis

$85.88

1.1 (1.30%)

08:47
01/07/19
01/07
08:47
01/07/19
08:47
Conference/Events
JPMorgan to hold a conference »

37th Annual Healthcare…

CELG

Celgene

$84.92

4.4 (5.46%)

NVS

Novartis

$85.88

1.1 (1.30%)

DXCM

DexCom

$116.24

3.83 (3.41%)

MOH

Molina Healthcare

$109.71

3.69 (3.48%)

BMRN

BioMarin

$87.06

2.935 (3.49%)

PFE

Pfizer

$42.99

0.95 (2.26%)

CAH

Cardinal Health

$44.90

0.75 (1.70%)

GILD

Gilead

$68.27

3.08 (4.72%)

VAR

Varian Medical

$118.76

8.93 (8.13%)

BAX

Baxter

$66.47

2.04 (3.17%)

ABC

AmerisourceBergen

$74.30

0.985 (1.34%)

EW

Edwards Lifesciences

$148.69

5.27 (3.67%)

ATRX

Atrix Laboratories

$0.00

(0.00%)

INCY

Incyte

$72.27

4.25 (6.25%)

JNJ

Johnson & Johnson

$127.80

1.99 (1.58%)

NBIX

Neurocrine

$74.76

5.32 (7.66%)

DVA

DaVita

$54.01

3.04 (5.96%)

INOV

Inovalon

$13.85

0.35 (2.59%)

SIEGY

Siemens

$0.00

(0.00%)

MRK

Merck

$76.26

2.22 (3.00%)

BIIB

Biogen

$318.19

11.62 (3.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 07

    Jan

  • 11

    Jan

  • 14

    Jan

  • 22

    Jan

  • 23

    Jan

  • 27

    Jan

  • 28

    Jan

  • 28

    Jan

  • 29

    Jan

  • 29

    Jan

  • 29

    Jan

  • 30

    Jan

  • 31

    Jan

  • 31

    Jan

  • 14

    Feb

  • 16

    Feb

  • 18

    Feb

  • 21

    Feb

  • 24

    Feb

  • 11

    Apr

  • 18

    May

  • 28

    May

CELG

Celgene

$84.50

17.85 (26.78%)

, BMY

Bristol-Myers

$44.71

-7.31 (-14.05%)

10:27
01/03/19
01/03
10:27
01/03/19
10:27
On The Fly
Alexion, Biogen seen as potential targets after Celgene buyout »

Shares of Celgene (CELG)…

CELG

Celgene

$84.50

17.85 (26.78%)

BMY

Bristol-Myers

$44.71

-7.31 (-14.05%)

ALXN

Alexion

$99.39

1.32 (1.35%)

BIIB

Biogen

$309.28

4.45 (1.46%)

AIMT

Aimmune

$24.00

-0.36 (-1.48%)

DCPH

Deciphera

$21.52

-0.9 (-4.01%)

BMRN

BioMarin

$84.31

-0.66 (-0.78%)

RIGL

Rigel Pharmaceuticals

$2.28

-0.07 (-2.98%)

FATE

Fate Therapeutics

$13.37

-0.15 (-1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jan

  • 03

    Jan

  • 03

    Jan

  • 03

    Jan

  • 06

    Jan

  • 24

    Jan

  • 28

    Jan

  • 29

    Jan

  • 18

    Feb

  • 18

    May

  • 20

    May

  • 28

    May

BMRN

BioMarin

$84.97

(0.00%)

, CELG

Celgene

$66.65

(0.00%)

09:40
01/03/19
01/03
09:40
01/03/19
09:40
Options
Unusually active option classes on open January 3rd »

Unusual total active…

BMRN

BioMarin

$84.97

(0.00%)

CELG

Celgene

$66.65

(0.00%)

TEVA

Teva

$15.84

(0.00%)

GILD

Gilead

$63.44

(0.00%)

JNUG

Direxion Daily Jr Gld Mnrs Bull 3X Shrs

$9.25

(0.00%)

ROKU

Roku

$32.49

(0.00%)

VALE

Vale

$13.48

(0.00%)

SBUX

Starbucks

$64.30

(0.00%)

NFLX

Netflix

$267.82

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jan

  • 06

    Jan

  • 28

    Jan

  • 18

    May

  • 28

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.